Osawa, M., Kudoh, S., Sakai, F., Endo, M., Hamaguchi, T., Ogino, Y., . . . Gemma, A. (2015). Clinical features and risk factors of panitumumab-induced interstitial lung disease: A postmarketing all-case surveillance study. Int J Clin Oncol.
Chicago Stili AlıntıOsawa, Masahiro, et al. "Clinical Features and Risk Factors of Panitumumab-induced Interstitial Lung Disease: A Postmarketing All-case Surveillance Study." Int J Clin Oncol 2015.
MLA AlıntıOsawa, Masahiro, et al. "Clinical Features and Risk Factors of Panitumumab-induced Interstitial Lung Disease: A Postmarketing All-case Surveillance Study." Int J Clin Oncol 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..